These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 19541822)

  • 21. Cytotoxic and apoptosis-inducing effects of bendamustine used alone and in combination with rituximab on chronic lymphocytic leukemia cells in vitro.
    Ziolkowska E; Wolowiec D; Cebula-Obrzut B; Blonski JZ; Smolewski P; Robak T; Korycka-Wolowiec A
    Postepy Hig Med Dosw (Online); 2014 Dec; 68():1433-43. PubMed ID: 25531707
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of bendamustine in combination with fludarabine in primary chronic lymphocytic leukemia cells.
    El-Mabhouh AA; Ayres ML; Shpall EJ; Baladandayuthapani V; Keating MJ; Wierda WG; Gandhi V
    Blood; 2014 Jun; 123(24):3780-9. PubMed ID: 24747434
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An essential role for p73 in regulating mitotic cell death.
    Toh WH; Nam SY; Sabapathy K
    Cell Death Differ; 2010 May; 17(5):787-800. PubMed ID: 20010785
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preclinical and clinical evaluation of forodesine in pediatric and adult B-cell acute lymphoblastic leukemia.
    Balakrishnan K; Ravandi F; Bantia S; Franklin A; Gandhi V
    Clin Lymphoma Myeloma Leuk; 2013 Aug; 13(4):458-66. PubMed ID: 23773454
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biallelic ATM inactivation significantly reduces survival in patients treated on the United Kingdom Leukemia Research Fund Chronic Lymphocytic Leukemia 4 trial.
    Skowronska A; Parker A; Ahmed G; Oldreive C; Davis Z; Richards S; Dyer M; Matutes E; Gonzalez D; Taylor AM; Moss P; Thomas P; Oscier D; Stankovic T
    J Clin Oncol; 2012 Dec; 30(36):4524-32. PubMed ID: 23091097
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Resveratrol increases rate of apoptosis caused by purine analogues in malignant lymphocytes of chronic lymphocytic leukemia.
    Podhorecka M; Halicka D; Klimek P; Kowal M; Chocholska S; Dmoszynska A
    Ann Hematol; 2011 Feb; 90(2):173-83. PubMed ID: 20714724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Therapy with the FCR regimen does not overcome chronic lymphocytic leukemia biology: aberrant p53 expression predicts response and survival.
    Zenz T; Stilgenbauer S
    Leuk Lymphoma; 2009 Oct; 50(10):1559-61. PubMed ID: 19701850
    [No Abstract]   [Full Text] [Related]  

  • 28. A novel role for p73 in the regulation of Akt-Foxo1a-Bim signaling and apoptosis induced by the plant lectin, Concanavalin A.
    Amin AR; Paul RK; Thakur VS; Agarwal ML
    Cancer Res; 2007 Jun; 67(12):5617-21. PubMed ID: 17575126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. GRAMD4 mimics p53 and mediates the apoptotic function of p73 at mitochondria.
    John K; Alla V; Meier C; Pützer BM
    Cell Death Differ; 2011 May; 18(5):874-86. PubMed ID: 21127500
    [TBL] [Abstract][Full Text] [Related]  

  • 30. P53, MDM-2, BAX and BCL-2 and drug resistance in chronic lymphocytic leukemia.
    Johnston JB; Daeninck P; Verburg L; Lee K; Williams G; Israels LG; Mowat MR; Begleiter A
    Leuk Lymphoma; 1997 Aug; 26(5-6):435-49. PubMed ID: 9389352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bendamustine is effective in p53-deficient B-cell neoplasms and requires oxidative stress and caspase-independent signaling.
    Roué G; López-Guerra M; Milpied P; Pérez-Galán P; Villamor N; Montserrat E; Campo E; Colomer D
    Clin Cancer Res; 2008 Nov; 14(21):6907-15. PubMed ID: 18980985
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Functional analysis of the ATM-p53-p21 pathway in the LRF CLL4 trial: blockade at the level of p21 is associated with short response duration.
    Lin K; Adamson J; Johnson GG; Carter A; Oates M; Wade R; Richards S; Gonzalez D; Matutes E; Dearden C; Oscier DG; Catovsky D; Pettitt AR
    Clin Cancer Res; 2012 Aug; 18(15):4191-200. PubMed ID: 22675167
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bendamustine in the treatment of chronic lymphocytic leukemia: results and future perspectives.
    Aivado M; Schulte K; Henze L; Burger J; Finke J; Haas R
    Semin Oncol; 2002 Aug; 29(4 Suppl 13):19-22. PubMed ID: 12170428
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simvastatin and purine analogs have a synergic effect on apoptosis of chronic lymphocytic leukemia cells.
    Podhorecka M; Halicka D; Klimek P; Kowal M; Chocholska S; Dmoszynska A
    Ann Hematol; 2010 Nov; 89(11):1115-24. PubMed ID: 20499237
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AICAR induces Bax/Bak-dependent apoptosis through upregulation of the BH3-only proteins Bim and Noxa in mouse embryonic fibroblasts.
    González-Gironès DM; Moncunill-Massaguer C; Iglesias-Serret D; Cosialls AM; Pérez-Perarnau A; Palmeri CM; Rubio-Patiño C; Villunger A; Pons G; Gil J
    Apoptosis; 2013 Aug; 18(8):1008-16. PubMed ID: 23605481
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanisms of action of the anti-VEGF monoclonal antibody bevacizumab on chronic lymphocytic leukemia cells.
    Bogusz J; Majchrzak A; Mędra A; Cebula-Obrzut B; Robak T; Smolewski P
    Postepy Hig Med Dosw (Online); 2013 Mar; 67():107-18. PubMed ID: 23475487
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Entinostat combined with Fludarabine synergistically enhances the induction of apoptosis in TP53 mutated CLL cells via the HDAC1/HO-1 pathway.
    Zhou Z; Fang Q; Li P; Ma D; Zhe N; Ren M; Chen B; He Z; Wang J; Zhong Q; Wang J
    Life Sci; 2019 Sep; 232():116583. PubMed ID: 31226417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic lymphocytic leukemia cells display p53-dependent drug-induced Puma upregulation.
    Mackus WJ; Kater AP; Grummels A; Evers LM; Hooijbrink B; Kramer MH; Castro JE; Kipps TJ; van Lier RA; van Oers MH; Eldering E
    Leukemia; 2005 Mar; 19(3):427-34. PubMed ID: 15674362
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bendamustine alone or with rituximab modifies expression of apoptosis-regulating genes and proteins of CLL cells, depending on IGVH mutational status.
    Ziolkowska E; Wolowiec D; Karpinski P; Blonski JZ; Lech-Maranda E; Borowiec M; Balcerczak E; Sasiadek M; Robak T; Korycka-Wolowiec A
    Leuk Lymphoma; 2019 Jun; 60(6):1409-1419. PubMed ID: 30187811
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chronic lymphocytic leukemia].
    Aoki S
    Rinsho Ketsueki; 2014 Feb; 55(2):213-22. PubMed ID: 24598189
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.